Skip to main content
    B

    Bioceres Crop Solutions Corp (BIOX)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ

    $0.20
    -0.01 (-4.90%)

    Market Cap: $13.40M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    Bioceres Crop Solutions Corp (BIOX) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Bioceres Crop Solutions (BIOX) trades at 0.3x book value. Its P/B of 0.3x is below its 5-year median of 2.4x. Its forward P/E is 15.0x.

    Current Multiples

    Its enterprise value is 86.8x its EBITDA. Its free cash flow yield is 568.4%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E15.0x
    Price to book0.3x
    EV/EBITDA86.8x
    Price to FCF0.2x
    EV/FCF3.2x
    PEGN/A
    FCF yield568.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 88.9% below 2.7x.

    MultipleCurrent5-year median10-year median
    P/SN/A1.6xN/A
    P/B0.3x2.4x2.7x
    Medians of month-end values through Oct 2026: 56 to 60 months (5-year) and 104 months (10-year).

    Valuation History

    Over the 3 of the 8 year ends shown that have a P/E, its P/E ranged from 40.4x in 2023 to 206.1x in 2024.

    Year endPriceP/EP/SP/B
    2025$1.31N/A0.3x1.1x
    2024$6.08206.1x1.0x1.2x
    2023$13.7340.4x1.9x2.9x
    2022$12.03N/A1.6x2.8x
    2021$14.14157.1x2.1x7.1x
    2020$6.20N/A1.4x4.0x
    2019$5.05N/A1.2x3.9x
    2018$10.07N/A0.2x0.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BIOX

    What is BIOX's forward P/E ratio?

    Bioceres Crop Solutions has a forward P/E ratio of 15.0x.

    Is BIOX stock overvalued?

    GNG's valuation label for BIOX is Undervalued.